Ensulizole

Ensulizole

SCHEMBL1072602

O=S(=O)(O)c1ccc2[nH]c(-c3ccccc3)nc2c1.c1ccncc1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.70
NPBWR1 P48145 2/20 0.52
SCD O00767 3/20 0.50
KDM4E B2RXH2 4/20 0.48
ALDH1A1 P00352 3/20 0.48
PKN1 Q16512 1/20 0.48
PKN2 Q16513 1/20 0.48
NPC1 O15118 4/20 0.48
RAB9A P51151 4/20 0.48
GAA P10253 1/20 0.48
CYP2C9 P11712 4/20 0.47
CYP2C19 P33261 4/20 0.47
CYP1A2 P05177 3/20 0.47
MAPT P10636 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
HPGD P15428 2/20 0.46
STAT1 P42224 1/20 0.46
CYP3A4 P08684 3/20 0.46
CYP2D6 P10635 1/20 0.46
LDHA P00338 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ensulizole SCHEMBL16277 0.93 HDAC6 (0.79) HDAC6NPBWR1SCDKDM4EALDH1A1
Ensulizole SCHEMBL29405567 0.93 HDAC6 (0.79) HDAC6NPBWR1SCDKDM4EALDH1A1
Ensulizole SCHEMBL4619449 0.93 HDAC6 (0.79) HDAC6NPBWR1SCDKDM4EALDH1A1
Ensulizole SCHEMBL2142368 0.92 HDAC6 (0.77) HDAC6NPBWR1SCDKDM4EALDH1A1
Ensulizole SCHEMBL1276069 0.92 HDAC6 (0.77) HDAC6NPBWR1SCDKDM4EALDH1A1
Ensulizole SCHEMBL17351653 0.92 HDAC6 (0.77) HDAC6NPBWR1SCDKDM4EALDH1A1
Ensulizole SCHEMBL3173650 0.92 HDAC6 (0.77) HDAC6NPBWR1SCDKDM4EALDH1A1
Ensulizole SCHEMBL22187023 0.91 HDAC6 (0.75) HDAC6NPBWR1SCDKDM4EALDH1A1
Ensulizole SCHEMBL27885503 0.91 HDAC6 (0.75) HDAC6NPBWR1SCDKDM4EALDH1A1
Ensulizole SCHEMBL1072605 0.90 HDAC6 (0.87) HDAC6NPBWR1SCDCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120184556-A1 SUBSTITUTED ENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2012-07-19 US disclosed
EP-2456310-A1 SUBSTITUTED BENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS Vanderbilt University (US) 2012-05-30 EP disclosed
WO-2011011722-A1 SUBSTITUTED BENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS VANDERBILT UNIVERSITY (US) 2011-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184556-A1 SUBSTITUTED ENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS GRM4, GRIK4, GRIA4 HDAC6 608/4885NPBWR1 1636/4885SCD 2100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.